About

I.              GENERAL INFORMATION ABOUT TURKISH JOURNAL OF OCCUPATIONAL / ENVIRONMENTAL MEDICINE AND SAFETY

A.   Mission and Scope

B.   Index

C.   Publisher

D.   Copyright/Permissions

 

II.            PREPARING MANUSCRIPTS

A.   Formatting

1.    Page Outline

2.    Article Type

B.   Writing the Article

1.    Cover letter

2.    Title Page

3.    Abstract

4.    Main Document

5.    References

6.    Tables and Figures

 

III.           MANUSCRIPT SUBMISSION

A.   How to Submit a Manuscript

B.   Correspondence between Authors and Journal

C.   Funding and Conflict of Interest Disclosures

D.   Protocols and Other Materials

E.   Related Work

F.    Confidentiality

G.   Acknowledgment of Receipt

 

IV.          REVIEW

A.   Internal review by Editors and Peer Review

B.   Criteria for Editorial Decisions

 

V.           RESEARCH AND PUBLICATION ETHICS

A.   Authorship

B.   Human Subjects

C.   Animal Subjects Research

D.   Scientific Misconduct and Breaches of Journal Policy or Ethical Standards


 

I. GENERAL INFORMATION ABOUT TURKISH JOURNAL OF OCCUPATIONAL / ENVIRONMENTAL MEDICINE AND SAFETY (TURJOEM)

 

A. Mission and Scope

The mission of Turkish Journal of Occupational / Environmental Medicine and Safety (TURJOEM) is to enhance knowledge and increase awareness in occupational and environmental medicine and occupational health and safety, among physicians, other health care professionals and other professionals in occupational health and safety.

To achieve this mission, TURJOEM publishes a wide variety of research including original articles, review articles, case reports and TURJOEM also publishes the outcomes (poster presentation abstracts etc.) of important meetings in the area.

 

B. Index

TURJOEM is indexed in Google Scholar.

 

C. Publisher

Engin Tutkun MD, PhD is the publisher of TURJOEM. He is a medical doctor with a PhD in Occupational Health and he worked at one of the 3 Occupational Disease Hospitals as director. Now he is an associate professor at Bozok University, Turkey.

 

D. Copyright/Permissions

All authors must transfer copyright to the TURJOEM. Transfer of copyright signifies transfer of rights for print publication; electronic publication; production of reprints, facsimiles, microfilm, or microfiche; or publication in any language. 

Authors are granted the rights after publication in TURJOEM to reuse the published article or portions thereof that they created as described here without requesting permission. These authors’ rights are to reuse figures and tables as part of new publications; include the article, or portions thereof, in their thesis, dissertation, or collection dedicated to their educational work; and provide copies to students in classes they teach. In all these cases for reuse, authors will give proper credit to the original publication in TURJOEM as follows:

“Reproduced with permission from Author(s). Title. TURJOEM. Year; vol: pp-pp. URL  

Authors reusing their material as described above do not need to contact TURJOEM for permission.

 


 

II. PREPARING MANUSCRIPTS

 

A. Formatting

The language of TURJOEM is English. However, the authors from Turkey may choose to add an abstract in Turkish, optionally. The manuscripts sent for publication should not have been published elsewhere or sent for publication. However, poster presentations that have not exceeded 300 words in scientific meetings before, can be accepted as conditional.

TURJOEM publishes a variety of article types, as listed below. The links accompanying each article type provide details about the article type and specific formatting requirements. General formatting guidelines are presented in the section following the article types. Original Research, Narrative Reviews, Systematic Reviews & Meta-analyses, Editorials, Letter to the Editors about observations and/or brief research reports, Case Reports.

 

1- Page Outline

The manuscript should be typed in a word processor program (Microsoft Word etc.), single-column format, double-spaced, 3 cm margins from each side, and 11-point type in Arial font.

All abbreviations in the text must be defined the first time they are used (both in the abstract and the main text), and the abbreviations should be displayed in parentheses after the definition. Abbreviations should be limited to those defined in the AMA Manual of Style, current edition. Authors should avoid abbreviations in the title and abstract and limit their use in the main text. 

Decimal points should be used in decimals throughout the manuscript. Measurements should be reported using the metric system according to the International System of Units (SI).

When a drug, product, hardware, or software mentioned within the main text product information, including the name of the product, producer of the product, city of the company and the country of the company should be provided in parenthesis in the following format: “Discovery St PET/CT scanner (General Electric, Milwaukee, WI, USA)”

 

2- Article Type

Identification of article type is the first step of manuscript submission because article type dictates the guidelines that should be used (see below, Using Guidelines), including formatting and word limits of the manuscript. The main categories of article type are outlined below:

 

Original Article: Original contributions are manuscripts containing substantial novel research. These articles can include randomized controlled trials, observational (cohort, case-control or cross-sectional) studies, destructive studies, diagnostic accuracy studies, systematic reviews and meta-analyses, nonrandomized behavioral and public health intervention trials, experimental animal trials, or any other clinical or experimental studies. Abstracts should not exceed 400 words and should be structured with the following subheadings: Background, Aims, Study Design (case control study, cross sectional study, cohort study, randomized controlled trial, diagnostic accuracy study, meta-analysis and systemic review, animal experimentation, non-randomized study in behavioral sciences and public health, etc.), Methods, Results, and Conclusion. The main text should be structured with the following subheadings: Introduction, Material and Methods, Results, Discussion, Acknowledgments, References, Tables, and Figure Legends. The main text should not exceed 3000 words, excluding the abstract, references, tables, and figure legends. There should be a maximum of 30 references.

 

Brief Reports: Brief reports are short and peer-reviewed articles including small case series, negative trials, the preliminary results and others that are not to be published as a full text paper. The main text should be less than 2000 words with a maximum 20 references and have no more than 3 display items (Tables or figures). Abstracts should not exceed 250 words and should be structured with the following subheadings: Aims, Methods, Results, and Conclusion. All papers require ethical approval.

 

Invited Review Article: Invited review articles are comprehensive analyses of specific topics in medicine, which are written upon invitation due to extensive experience and publications of authors on the review subjects. All invited review articles will also undergo peer review prior to acceptance. Review articles must not exceed 5000 words for the main text (excluding references, tables, and figure legends) and 400 words for the abstract. A review article can be signed by no more than 5 authors and can have no more than 80 references.

 

Case Report: Interesting rare cases containing a substantial novel finding can be reported. Cases should be unique, representing a diagnostic or therapeutic challenge and having a learning point for the readers. Abstracts of case reports should mainly include information about the case and should be limited to a maximum of 250 words. The abstract must begin on a separate page and should be structured with the following subheadings: Background, Case Report and Conclusion. The main text of case reports should be structured with the following subheadings: Introduction, Case Report, Discussion, and References. Case reports must not exceed 1200 words (excluding references, tables, and figure legends). Case reports can be signed by no more than 5 authors and can have no more than 10 references and 5 figures or tables.

 

Clinical Image: For educational purposes, the journal publishes original, interesting, and high quality clinical images having a brief explanation (maximum 500 words excluding references but including figure legends) and of educational significance. The figure legend should contain no more than 100 words. It can be signed by no more than 5 authors and can have no more than 5 references and 1 figure or table. Any information that might identify the patient or hospital, including the date, should be removed from the image. An abstract is not required with this type of manuscripts. The main text of clinical images should be structured with the following subheadings: Case, and References.

 

Letter to the Editor: Letters in reference to a journal article must not exceed 500 words (excluding references). Letters not related to a journal article must also not exceed 500 words (excluding references). An abstract is not required with this type of manuscripts. A letter can be signed by no more than 4 authors and can have no more than 5 references and 1 figure or table.

 

Other: Editorials, reviewer commentaries, book reviews, and reports on publication and research ethics are requested by the Editorial Board.

 

Authors may refer to the guidelines below for different article types when preparing their manuscript:

CONSORT (http://www.consort-statement.org/home/)

CONSORT translations (www.consort-statement.org/consort-statement/translations/)

Standard protocol items for randomized trials

SPRIT (http://www.spirit-statement.org/)

Observational research: cohort, case-control, and cross-sectional studies

STROBE (www.strobe-statement.org/)

Diagnostic accuracy studies

STARD (www.stard-statement.org/)

Systematic reviews and meta-analyses

PRISMA (www.prisma-statement.org/)

Non-randomized behavioral and public health intervention trials

TREND (www.cdc.gov/trendstatement/)

Experimental animal trials

ARRIVE (www.nc3rs.org.uk/arrive/)

For further information on the reporting guidelines for health research, authors are suggested to refer to the EQUATOR network website (http://www.equator-network.org/)

 

B. Writing the Article

 

1- Cover letter

The cover letter should include the article title, article type, and the full name of the corresponding author. The corresponding author should briefly summarize why his/her paper is a valuable addition to the scientific literature and specify the type of article he/she is submitting (for example, original article, case report, review article, clinical image). The cover letter should also include a statement declaring the absence or presence of a conflict of interest.

Furthermore, there should be a statement that the manuscript has not already been published, accepted or under simultaneous review for publication elsewhere. Balkan Medical Journal does not accept multiple submission and duplicate submission even though the previous one was published in a different language.

For manuscripts that have been presented orally or as a poster, this must be stated on the title page with the date and the place of the presentation. An example of a cover letter can be found on the journal’s webpage.

 

2- Title Page

Title page should include;

The complete manuscript title (no more than 150 characters)

The running head (no more than 50 characters)

Word counts for the abstract and text (the text word count does not include references, tables, and figure legends)

The number of references, and the number of figures and tables

All authors' full names, affiliations and e-mail addresses (List authors in the order in which they are to appear in the byline of the published article.)

The name, address, telephone numbers and email address of the corresponding author

Keywords (3-6)

Information about where and when the study has previously been presented.

Acknowledgements: All contributors who do not meet the criteria for authorship and the statement of conflict of interest and funding should be declared under this subheading.

Acknowledge only persons who have contributed to the scientific content or provided technical support. Authors must obtain written permission from anyone they list in the Acknowledgments section, including confirmation of the nature of the contribution. The corresponding author must also affirm that he or she has listed everyone who contributed significantly to the work in the Acknowledgments.

TURJOEM follows the International Committee of Medical Journal Editors (ICMJE) recommendations for defining authors and contributors.

 

3- Abstracts

Original articles, invited review articles and case reports should include an abstract. Abstracts for original articlesshould be structured with the following subheadings: Background and Aims, Study design, Methods, Results, and Conclusion.

Abstracts for case reports should be structured with the following subheadings: Background, Case Report, and Conclusion.

Abstracts for review articles should not be structured.

Clinical images, Editorials, Letters to the Editor, and Commentaries should not contain an abstract.

 

4- Main Document

The main document should include the main text, the reference list, tables, and figure legends, respectively.

Any information that may indicate an individual or institution should be excluded from the main document to ensure a blinded review process.

Please note, the abstract should be submitted through the submission system and should not be included in the main document.

 

5- References

Authors are encouraged to cite primary literature rather than review articles to give credit to those who have performed the original work. While citing publications, preference should be given to the latest, most up to date publications. Authors are responsible for the accuracy of references.

Reference listings must be in accordance with ICMJE standards and numbered consecutively at the end of the manuscript in the order in which they are mentioned in the text.

Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus/ Medline/PubMed (for journal abbreviations consult the List of Journals indexed for MEDLINE, published annually by NLM). When there are 6 or less authors, all authors should be listed. If there are 7 or more authors the first 6 authors should be listed followed by “et al”. In the main text of the manuscript, references should be cited using Arabic numbers in parentheses. The reference styles for different types of publications are presented in the following examples:

 

Journal Article: Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37(11): 1593-601.

 

Book: Guttman L. Spinal Cord Injuries: Comprehensive management and research 2nd edition. London: Blackwell Scientific Publications, 1976: 353-4.

 

Book Chapter: Zvaifler NJ. Antimalarials. In: McCarty DJ (ed). Arthritis and Allied Conditions. Philadelphia: Lea and Febiger, 1985: 497-501.

 

Oral Presentations: Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Reinhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland. North-Holland; 1992. p. 1561-5.

 

Web Pages: Morse SS. Factors in the emergence of infectious disease. Emerg Infect Dis [serial online] 1995 1(1): [24 screens]. Available from: URL: http://www/cdc/gov/ncidoc/EID/eid.htm.

 

6- Tables and Figures

Tables should not be presented within the main document and be prepared in another word document. All tables should be referred to within the main text and they should be numbered consecutively in the order they are referred to within the main text. A descriptive title should be provided for all tables and the titles should be placed above the tables. Abbreviations used in the tables should be defined below the tables (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software and they should be arranged clearly to provide a simple reading.

Figures, graphics and photographs should be submitted as separate files (in TIFF or JPEG format) through the submission system. They should not be embedded in a Word document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system. Images should not be labelled (a, b, c, etc.) to indicate figure subunits. Thick and thin arrows, arrowheads, stars, asterisks and similar marks can be used on the images to support figure legends. Like the rest of the submission, the figures too should be blind. Any information within the images that may indicate an individual or institution should be blinded. The minimum resolution of each submitted figure should be 300DPI. To prevent delays in the evaluation process all submitted figures should be clear in resolution and large in size (minimum dimensions 100x100 mm). Figure legends should be listed at the end of the main document.

 


 

III. MANUSCRIPT SUBMISSION AND REVIEW

 

A. How to Submit a Manuscript

We accept submissions only through Dergipark manuscript submission system (www.dergipark.gov.tr). Please do not submit manuscripts as electronic mail attachments or by regular mailTURJOEM does not charge author submission or publication fees.

 

B. Correspondence between Authors and TURJOEM

Electronic mail is the main form of correspondence between authors and the journal and authors must provide accurate, active e-mail addresses for each author at the time of manuscript submission and update these addresses as necessary during the review process. Although the corresponding author serves as the first contact for all communication about manuscripts submitted to TURJOEM, all authors receive copies of reviews and editorial correspondence. It is the corresponding author’s responsibility to coordinate responses to requests for revision and questions about the work under review. Any author, however, should contact the editors if they perceive problems related to what is being communicated by the corresponding author.

If the list of authors changes between submission and final acceptance of an article, it is the corresponding author’s responsibility to explain the changes to the editors in writing and to obtain written documentation that all the authors (including any deleted and added authors) approve of the author changes.

 

C. Funding and Conflict of Interest Disclosures

At the time of manuscript submission, TURJOEM requires corresponding authors to summarize all authors’ conflict of interest disclosures. Failure to provide accurate information about potential conflicts of interest at the time of submission will be viewed as a breach of author responsibility and could negatively affect publication decisions. We provide the summary information collated by the corresponding author to editors and peer reviewers.

In the Methods section of the text, authors must state the conflict of interest status, and if available, the funding source for the work and describe the role(s) of the funding organization in the design of the study and the decision to approve publication of the finished manuscript. If the funding source had no such involvement, the authors should state that.

 

D. Other Materials

If your submission describes the results from a survey or questionnaire, please submit a copy of these materials as it will improve the speed and quality of the review process. Other associated files that you may consider submitting include but are not limited to the following:

§  Cover letter with specific points that you want to make to the editors

§  Studies related to the submission that have been accepted for publication or published

§  Reviews of this submission from other journals

 

E. Related Work, Duplicate Publication, and Use of Previously Published Material in Submitted Manuscripts

Manuscripts are considered for publication with the understanding that no part of their contents are under consideration for publication elsewhere; have not been published or posted elsewhere; and will not be posted or published elsewhere, except in abstract form or with the express consent of the Editor and Publisher.

Authors should give full details on any possible previous or duplicate publication of any content of the manuscript in the cover letter. They should include copies of published papers and manuscripts of papers that are in preparation, under review, or in press that contain data or other content that appears in the submitted manuscript. Editors use these materials when making judgments about duplicate publication.

 

F. Confidentiality

The staff at TURJOEM keeps author correspondence confidential, unless it is intended for publication (e.g., as a comment on a published article). We also ask that authors and reviewers keep editorial correspondence confidential, and that authors refrain from sharing either the correspondence itself or the essence of its content with individuals who are not their collaborators. Maintaining such confidentiality helps ensure that editors can offer advice that is in the best interests of authors’ papers without concern for how it might be considered or used by others.

 

G. Acknowledgment of Receipt

We acknowledge all manuscripts and assign each a unique, confidential manuscript number. We provide all authors with instructions for checking the status of the manuscript online. The status of the manuscript can be checked online.

 


 

IV. REVIEW

 

A. Internal Review by Editors and External Peer Review

At least 1 Editor and 1 Associate Editor read each manuscript. Together, they decide whether to send the paper to outside reviewers. If a paper is rejected without external review, authors are notified electronically within 1 to 2 weeks of receipt. We retain copies of rejected manuscripts for 60 days, after which we delete them from our system.

We send about 50% of submitted papers for external peer review, usually to at least 2 reviewers. The reviewers are selected from the advisory board of TURJOEM. We ask reviewers to declare potential conflicts of interest and to decline the opportunity to review if they think that a close personal or professional relationship with any of the authors could lead to a biased review. Authors may list individuals who they do not want to be a reviewer, but must justify their request in the cover letter.

 

B. Criteria for Editorial Decisions

All the submitted papers are object to editorial review. TURJOEM can publish a substantial fraction of all papers submitted. The editorial process is double-blinded. Reviewers make recommendations about accepting or rejecting the submitted paper. Almost all papers that we accept require editorial or statistical revision before publication. Editorial assistance includes, but is not limited to, providing specific guidance regarding transparent reporting of items mentioned in pertinent reporting standards (e.g., CONSORT, PRISMA). Of note, to check or clarify analyses and findings, editors may ask researchers to provide the raw data for their studies during review or if concerns about scientific integrity arise after publication.

We send the reviewers’ comments to authors whether or not we accept the article. The publication time after acceptance is approximately  months.

 


 

V. RESEARCH AND PUBLICATION ETHICS

TURJOEM  follows the recommendations, policies, guidance, and processes related to research and publication ethics developed by the International Committee of Medical Journal Editors, the Council on Publication Ethics, and the Council of Science Editors. These sources provide information about issues such as authorship criteria, duplicate publication, scientific misconduct, defining and managing potential conflicts of interest, editorial independence, retraction of publications, and the treatment of research participants.

 

A. Authorship

TURJOEM  follows the International Committee of Medical Journal Editors recommendations for defining authors and contributors (see: www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html). The ICMJE recommends basing authorship on the following 4 criteria: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND drafting the work or revising it critically for important intellectual content; AND final approval of the version to be published; AND agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In addition to being accountable for the parts of the work they have done, authors should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

 

B. Human Subjects Research

Research that involves human participants also includes investigations that use only human blood, tissue, or medical records. The authors must confirm review of the study by the appropriate institutional review board or affirm that the protocol is consistent with the principles of the Declaration of Helsinki(http://www.healthscience.net/resources/declaration-of-helsinki/). If the authors did not obtain institutional review board approval before the start of the study, they should so state and explain the circumstances. If the study was exempt from review, the authors must state that such exemption complied with the policy of their local institutional review board. They should affirm that study participants gave their informed consent or state than an institutional review board approved conduct of the research without explicit consent from the participants.

If patients are identifiable from illustrations, photographs, pedigrees, case reports, or other study data, the authors must attest in writing that they have obtained signed release from each such individual (or copies of the figures with the appropriate release statement) giving permission for publication with the manuscript. To maintain confidentiality about the identity of subjects, authors should not submit these permission forms to the journal but must keep them on record.

These reviews, permissions and other forms must be revealed in the materials and methods section.

 

C. Animal Subjects Research

These studies should have ethical board approval from appropriate institutions. The studies conducted in Turkey should be in accordance with the codes of HADYEK-HADMEK. Studies from other countries should be in accordance with their national ethical codes which are coherent with Turkish regulations.

 

D. Scientific Misconduct and Breaches of Journal Policy or Ethical Standards

In addition to breaches in procedures related to human subjects, research misconduct includes issues related to the fabrication or falsification of data, and plagiarism. Violations of publication ethics include duplicate publication, misrepresentation of author contributions, and failure to disclose potential financial conflicts of interest. Should the Editors suspect research misconduct or violations of publication ethics related to manuscripts submitted for review, the journal reserves the right to notify and forward the submitted manuscript to the chief executive officer and/or dean of the sponsoring institution, the funding institution, or other appropriate authority for investigation.